Clinical Trials Browser

Not yet recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × ARQ531 × Clear all

NCT07194980 2026-04-20

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell